| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |